AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Phase of Trial: Phase III
Latest Information Update: 22 Mar 2019
Price : $35 *
At a glance
- Drugs Apixaban (Primary) ; Aspirin
- Indications Stroke
- Focus Therapeutic Use
- Acronyms ARCADIA
- 08 Feb 2019 As of November 5, 2018, 434 subjects have been consented, of whom 113 have been randomized as per trial design presented at the International Stroke Conference 2019.
- 08 Feb 2019 Trial design presented at the International Stroke Conference 2019
- 17 Feb 2018 Planned primary completion date changed from 31 Oct 2021 to 18 Jan 2022.